Loading clinical trials...
Loading clinical trials...
The Effect of Dexmedetomidine as an Adjuvant for Lower Limb Nerve Blocks Following Oromaxillofacial Reconstruction
Conditions
Interventions
0.3% ropivacaine and 50 μg dexmedetomidine
Ropivacaine
Locations
1
China
School & Hospital of Stomatology, China Medical University
Shenyang, Liaoning, China
Start Date
April 20, 2017
Primary Completion Date
July 31, 2017
Completion Date
July 31, 2017
Last Updated
April 18, 2017
Lead Sponsor
Xiaofeng Bai
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions